Adorx Therapeutics

Developer of small molecule based therapeutics for cancer treatment

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2017 groups1 employees language adorx.com

Registered entities

Investor mix

8 investors on record; lead investors include Epidarex Capital.

Investor typeCountShare
Venture capital225%
Other / undisclosed675%
Coming soon